Cutting-Edge Sonablate HIFU Technology for Precision Treatment of Prostate Cancer Debuts in Delhi

New Delhi: Sonablate Introduces Revolutionary Sonablate HIFU Technology for Precise Prostate Treatment in Delhi.

Sonablate, a pioneering medical technology company, has proudly unveiled its latest innovation at the renowned Rajiv Gandhi Cancer Institute and Research Centre in Delhi. The Sonablate HIFU (High-Intensity Focused Ultrasound) technology represents a groundbreaking advancement in prostate care. This minimally invasive robotic device delivers precise and focused ablative energy to patients with prostate conditions. As the authorized distributor in India, NovoMed Incorporation Pvt Ltd ensures widespread availability of the Sonablate HIFU Robotic Device.

The key highlight of Sonablate HIFU Technology lies in its unique customization capabilities. By precisely targeting the affected prostate issue, it dramatically reduces the risk of collateral damage to surrounding healthy tissues. This groundbreaking procedure is also non-invasive, radiation-free, and bloodless, resulting in significantly shorter recovery periods for patients. With Sonablate HIFU Technology’s arrival in Delhi, patients now have access to a comprehensive, patient-centric solution for prostate treatment, delivering exceptional precision and minimal discomfort.

Speaking on the occasion, Dr Sudhir Rawal, Medical Director and Chief of GenitoUro – Oncology Services, Rajiv Gandhi Cancer Institute and Research Centre, opined, “Our Institute has been using this machine since February, 2023 and till now it has been working smoothly. It is a user-friendly device which requires proper training prior to the onset of the program. This procedure gives minimal discomfort and the least side effects to the patient with adequate treatment for the disease. Intraoperative and postoperative complications of Radical prostatectomy (RALP) like pain, erectile dysfunction, urinary incontinence etc. are avoided. Also, the side effects of radiation like GI toxicity, hematuria etc. are avoided. The patient also has an option of surgical, or radiation treatment if there is recurrence.”

Harinder Singh Ratra, an eighty year old patient of Dr Sudhir Rawal, from Punjab, expressed his deep gratitude and stated,” The procedure was performed on me in the month of June. It was done very efficiently and professionally and I recovered within a week. On a follow up visit in the month of September, the MRI scan showed no sign of disease. Dr Sudhir Rawal and his team of dedicated professionals have given me a new lease on life.”

Dr Sudhir Rawal averred, “With the rise in early detection of prostate cancer and patient’s concern for preserving sexual function and avoiding urinary incontinence with very early discharge, the prospects for this technology appear to be bright.” Patients from neighboring countries like Bangladesh have also taken optimum advantage of this technology at the Rajiv Gandhi Gandhi Cancer Institute and Research Centre, and have been successfully treated by Dr Sudhir Rawal and his team.

Jay Mehta, Director- Sales, NovoMed Incorporation Pvt Ltd, aptly sums it up by asserting, “We are thrilled to introduce Sonablate HIFU Technology, a game changer in the field of prostate care. This significant advancement in healthcare technology will ensure a highly improved quality of life for patients with prostate conditions.”